Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression-Reference-Cited by-同舟云学术

Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression

Published:2015-01-05 Issue:1 Volume:16 Page:1111-1130
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

De Berardis Domenico,Fornaro Michele,Serroni Nicola,Campanella Daniela,Rapini Gabriella,Olivieri Luigi,Srinivasan Venkataramanujam,Iasevoli Felice,Tomasetti Carmine,De Bartolomeis Andrea,Valchera Alessandro,Perna Giampaolo,Mazza Monica,Di Nicola Marco,Martinotti Giovanni,Di Giannantonio Massimo

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/16/1/1111/pdf

Reference100 articles.

1. Role of melatonin in mood disorders and the antidepressant effects of agomelatine

2. The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice

3. Antidepressant action of agomelatine (S 20098) in a transgenic mouse model

4. The mechanism, efficacy, and tolerability profile of agomelatine

5. Circadian rhythm of mt1 melatonin receptor expression in the suprachiasmatic nucleus of the C3H/HeN mouse1

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study Protocol for Assessing the Effectiveness of Agomelatine on the Severity and Frequency of Episodic Migraine Attacks Without Aura: A Randomized Triple-Blind, Placebo-Controlled Trial;Shiraz E-Medical Journal;2024-04-23

2. Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates;Sleep Medicine;2024-01

3. Agomelatine efficacy in treatment resistant obsessive-compulsive disorder: A randomized double-blind clinical trial;The International Journal of Psychiatry in Medicine;2023-12-29

4. Agomelatine ameliorates doxorubicin-induced cortical and hippocampal brain injury via inhibition of TNF-alpha/NF-kB pathway;Toxicology Mechanisms and Methods;2023-12-13

5. Changes of Serum C-Reactive Protein Level in Patients With Depressive Disorders After Treatment With Agomelatine Combined With Aerobic Exercise and Its Significance;Clinical Neuropharmacology;2023-09